TITLE

Recruiting and retaining diverse CR subjects requires focused strategies

PUB. DATE
June 2008
SOURCE
Clinical Trials Administrator;Jun2008, Vol. 6 Issue 6, p63
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article discusses the issue of recruiting minority or diverse populations as participants in clinical research. Accordingly, the strategies for improving diversity in clinical research studies include the recruitment as well as the retention of diverse populations. Background information on the Eliminating Disparities In Clinical Trials research project is also presented. Also noted are insights from clinical trial administrators.
ACCESSION #
32138514

 

Related Articles

  • Clinical Trials in New Europe. DOIG, AL // Bio-IT World;Jan2009, Vol. 8 Issue 1, p13 

    The article presents an outlook for clinical trials in New Europe for 2009. The collapse of the Soviet Union is cited as one of the major factors which contributed to the emergence of new opportunity for clinical trials in Europe. An overview of the report from Insight Pharma Reports entitled...

  • Relevance of the clinical impact factor. Blitzkow, Gilson; Estrela, Carlos // Dental Press Endodontics;Jan-Apr2015, Vol. 5 Issue 1, p5 

    The author discusses the importance of systematic literature reviews to analyze clinical impact factors and select accurate and appropriate articles.

  • Database recruitment: a solution to poor recruitment in randomized trials? Stuardi, Tracy; Cox, Helen; Torgerson, David J // Family Practice;Jun2011, Vol. 28 Issue 3, p329 

    Background. Achieving sample size is imperative to obtaining sufficient power to detect potential effects in health care research, yet many research studies are prone to under-recruitment. Not only does this create problems with power but also it contributes to research extensions, additional...

  • clinical trial.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p467 

    An encyclopedia entry for "clinical trial" is presented. It refers to an investigation of drug administration on human subjects to define the clinical efficacy and pharmacological effects. It addresses a variety of issues such as the treatment and diagnosis of disease. Particular focus is given...

  • Clinical trials in India: Where do we stand globally? Selvarajan, Sandhiya; George, Melvin; S., Suresh Kumar; Dkhar, Steven Aibor // Perspectives in Clinical Research;Jul-Sep2013, Vol. 4 Issue 3, p160 

    Aims: To evaluate the trend of clinical trials in India over the last 4 years compared to the well-established countries using clinical trial registries since the advent of clinical trial registry of India (CTRI). Materials and Methods: The data of clinical trials registered in India, United...

  • Latin America Research Stats.  // Applied Clinical Trials;Aug2011, Vol. 20 Issue 8, p16 

    The article discusses a survey on the difference between the attitude of the U.S. and Latin American investigators in clinical trials. The poll has revealed that both U.S. and Latin American investigators emphasize the importance of medical innovation. However, Latin American investigators are...

  • A tutorial on sensitivity analyses in clinical trials: the what, why, when and how. Thabane, Lehana; Mbuagbaw, Lawrence; Zhang, Shiyuan; Samaan, Zainab; Marcucci, Maura; Chenglin Ye; Thabane, Marroon; Giangregorio, Lora; Dennis, Brittany; Kosa, Daisy; Debono, Victoria Borg; Dillenburg, Rejane; Fruci, Vincent; Bawor, Monica; Juneyoung Lee; Wells, George; Goldsmith, Charles H. // BMC Medical Research Methodology;2013, Vol. 13 Issue 1, p1 

    Background: Sensitivity analyses play a crucial role in assessing the robustness of the findings or conclusions based on primary analyses of data in clinical trials. They are a critical way to assess the impact, effect or influence of key assumptions or variations-such as different methods of...

  • Subjective endpoints in clinical trials: the case for blinded independent central review. Walovitch, Richard; Bin Yao; Chokron, Patrick; Helen Le; Bubley, Glenn // Open Access Journal of Clinical Trials;2013, Vol. 5, p111 

    Primary efficacy and safety endpoints in clinical trials are often subjective assessments made by site personnel. For international confirmatory trials conducted over broad geographic regions and different clinical practice settings, variability in these subjective assessments can be...

  • Sum > parts: Building a high performance CR team.  // Clinical Trials Administrator;Dec2009, Vol. 7 Issue 12, p139 

    The article outlines steps that clinical research (CR) sites can take when developing a high performance clinical trial research team. Emphasis is given on the importance of starting a chartering process which involves understanding the team's purpose as well as the need to keep organization's...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics